Biodesix (NASDAQ:BDSX) CEO Scott Hutton recently sold 1,490 shares of the company’s stock for approximately $19,042, reducing his ownership by 2.96%. This transaction follows previous insider sales in February and January. Analysts currently rate Biodesix as a “Moderate Buy” with a consensus price target of $32.50, while institutional ownership stands at around 21%.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Insider Selling: Biodesix (NASDAQ:BDSX) CEO Sells 1,490 Shares of Stock
Biodesix (NASDAQ:BDSX) CEO Scott Hutton recently sold 1,490 shares of the company’s stock for approximately $19,042, reducing his ownership by 2.96%. This transaction follows previous insider sales in February and January. Analysts currently rate Biodesix as a “Moderate Buy” with a consensus price target of $32.50, while institutional ownership stands at around 21%.